- First Glide Flight with Lead Spaceship, Apeiron, Expected in January, and First Commercial Spaceflight Expected Early Q2 2027
- Second Spaceship Expected to Begin Commercial Spaceflight in Late Q2/Early Q3 2027
- New High-Cadence Launch Hangar and Fueling Infrastructure (Planned Opening in 2H 2028) Expected to Increase Spaceflight Capacity by 20% to 150 Spaceflights Per Year
- 100+ Astronauts Begin Preparations for Upcoming Spaceflights, While Limited Availability of Spaceflight Expedition Bookings Opened at
$850k Per Seat
“Spaceship Apeiron’s arrival at Spaceport America shifts our focus towards operational readiness, as we now prepare for flight test and the launch of commercial spaceflight," said
Third Quarter 2026 Financial Highlights
- Cash, cash equivalents and marketable securities total
$184 million as ofSeptember 30, 2026 .
- Revenue of
$0.4 million , consistent with the third quarter of 2025, attributable to access fees related to future astronauts and a future astronaut event.
- GAAP total operating expenses of
$59 million , compared to$67 million in the third quarter of 2025. Non-GAAP total operating expenses of$49 million in the third quarter of 2026, compared to$58 million in the third quarter of 2025.
- Net loss of
$59 million , compared to a$64 million net loss in the third quarter of 2025, with the improvement primarily driven by lower operating expenses in 2026.
- Adjusted EBITDA totaled
$(47) million , compared to$(53) million in the third quarter of 2025, with the improvement primarily driven by lower operating expenses in 2026.
- Net cash used in operating activities totaled
$58 million , compared to$56 million in the third quarter of 2025.
- Cash paid for capital expenditures totaled
$41 million , compared to$51 million in the third quarter of 2025.
- Free cash flow totaled
$(99) million , compared to$(108) million in the third quarter of 2025.
Business Updates
- Completed construction of the rocket motor production facility within the
Spaceship Factory inArizona , with final occupancy approval pending. Preparations for assembly-line production are underway.
- Began booking limited tranche of Spaceflight Expeditions at
$850,000 per seat.
Financial Guidance
The following forward-looking statements reflect our expectations for the fourth quarter of 2026 as of
- Free cash flow for the fourth quarter of 2026 is expected to be in the range of
$(80) million to$(90) million .
Non-GAAP Financial Measures
In addition to the Company’s results prepared in accordance with generally accepted accounting principles in
Conference Call Information
About
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our spaceflight systems, our planned timeline for testing, glide flights and commercial service using our Spaceships, our growth projects and their anticipated benefits, the planned opening of our high-cadence launch hangar and fueling infrastructure and the timing and benefits thereof, including increased spaceflight capacity, our plans for our rocket motor production facility, our objectives for future operations, growth plans and the Company’s financial forecasts, including our expected free cash flow in the fourth quarter of 2026, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “potential,” “continue,” “anticipate,” “intend,” “expect,” “strategy,” “future,” “could,” “would,” “project,” “plan,” “target,” and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to any delay in future commercial flights of our spaceflight fleet, our ability to successfully develop and test our next generation vehicles, and the time and costs associated with doing so, our expected capital requirements and the availability of additional financing, and the other factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended
Third Quarter 2026 Financial Results
Condensed Consolidated Statements of Operations and Comprehensive Loss | ||||||||||||||||
(In thousands, except per share amounts) | ||||||||||||||||
|
| Three Months Ended |
| Nine Months Ended | ||||||||||||
|
| 2026 |
| 2025 |
| 2026 |
| 2025 | ||||||||
|
|
|
|
|
|
|
|
| ||||||||
Revenue |
| $ | 427 |
|
| $ | 365 |
|
| $ | 788 |
|
| $ | 1,232 |
|
|
|
|
|
|
|
|
|
| ||||||||
Operating expenses: |
|
|
|
|
|
|
|
| ||||||||
Spaceline operations |
|
| 28,272 |
|
|
| 19,497 |
|
|
| 86,094 |
|
|
| 54,529 |
|
Research and development |
|
| 2,567 |
|
|
| 14,952 |
|
|
| 13,618 |
|
|
| 68,383 |
|
Selling, general and administrative |
|
| 24,493 |
|
|
| 27,965 |
|
|
| 78,600 |
|
|
| 90,365 |
|
Depreciation and amortization |
|
| 4,089 |
|
|
| 4,117 |
|
|
| 11,988 |
|
|
| 12,511 |
|
Total operating expenses |
|
| 59,421 |
|
|
| 66,531 |
|
|
| 190,300 |
|
|
| 225,788 |
|
|
|
|
|
|
|
|
|
| ||||||||
Operating loss |
|
| (58,994 | ) |
|
| (66,166 | ) |
|
| (189,512 | ) |
|
| (224,556 | ) |
|
|
|
|
|
|
|
|
| ||||||||
Interest income |
|
| 1,979 |
|
|
| 4,966 |
|
|
| 7,076 |
|
|
| 18,013 |
|
Interest expense |
|
| (1,732 | ) |
|
| (3,250 | ) |
|
| (5,554 | ) |
|
| (9,737 | ) |
Gain on extinguishment of debt |
|
| — |
|
|
| — |
|
|
| 8,639 |
|
|
| — |
|
Other income, net |
|
| 21 |
|
|
| 33 |
|
|
| 81 |
|
|
| 107 |
|
Loss before income taxes |
|
| (58,726 | ) |
|
| (64,417 | ) |
|
| (179,270 | ) |
|
| (216,173 | ) |
Income tax expense |
|
| 30 |
|
|
| — |
|
|
| 90 |
|
|
| 11 |
|
Net loss |
|
| (58,756 | ) |
|
| (64,417 | ) |
|
| (179,360 | ) |
|
| (216,184 | ) |
Other comprehensive loss: |
|
|
|
|
|
|
|
| ||||||||
Foreign currency translation adjustment |
|
| 1 |
|
|
| (6 | ) |
|
| (9 | ) |
|
| 12 |
|
Unrealized gain (loss) on marketable securities |
|
| 9 |
|
|
| 239 |
|
|
| (57 | ) |
|
| (71 | ) |
Total comprehensive loss |
| $ | (58,746 | ) |
| $ | (64,184 | ) |
| $ | (179,426 | ) |
| $ | (216,243 | ) |
|
|
|
|
|
|
|
|
| ||||||||
Net loss per share: |
|
|
|
|
|
|
|
| ||||||||
Basic and diluted |
| $ | (0.39 | ) |
| $ | (1.09 | ) |
| $ | (1.57 | ) |
| $ | (4.61 | ) |
|
|
|
|
|
|
|
|
| ||||||||
Weighted-average shares outstanding: |
|
|
|
|
|
|
|
| ||||||||
Basic and diluted |
|
| 151,596 |
|
|
| 59,252 |
|
|
| 114,209 |
|
|
| 46,865 |
|
Condensed Consolidated Balance Sheets | ||||||||
(In thousands) | ||||||||
|
|
| ||||||
Assets |
|
|
|
| ||||
Current assets: |
|
|
|
| ||||
Cash and cash equivalents |
| $ | 144,007 |
|
| $ | 144,727 |
|
Restricted cash |
|
| 31,293 |
|
|
| 30,988 |
|
Marketable securities |
|
| 8,991 |
|
|
| 162,313 |
|
Other current assets |
|
| 26,022 |
|
|
| 34,870 |
|
Total current assets |
|
| 210,313 |
|
|
| 372,898 |
|
Property, plant and equipment, net |
|
| 500,329 |
|
|
| 388,730 |
|
Other non-current assets |
|
| 36,381 |
|
|
| 41,551 |
|
Total assets |
| $ | 747,023 |
|
| $ | 803,179 |
|
Liabilities and Stockholders’ Equity |
|
|
|
| ||||
Current liabilities: |
|
|
|
| ||||
Accounts payable |
| $ | 17,886 |
|
| $ | 15,163 |
|
Current portion of long-term debt |
|
| 30,098 |
|
|
| 47,830 |
|
Customer deposits |
|
| 80,460 |
|
|
| 78,535 |
|
Other current liabilities |
|
| 52,557 |
|
|
| 67,795 |
|
Total current liabilities |
|
| 181,001 |
|
|
| 209,323 |
|
Non-current liabilities: |
|
|
|
| ||||
Long-term debt |
|
| 186,242 |
|
|
| 276,362 |
|
Other long-term liabilities |
|
| 36,278 |
|
|
| 43,530 |
|
Total liabilities |
|
| 403,521 |
|
|
| 529,215 |
|
Stockholders’ Equity |
|
|
|
| ||||
Common stock |
|
| 15 |
|
|
| 7 |
|
Additional paid-in capital |
|
| 3,274,560 |
|
|
| 3,025,604 |
|
Accumulated deficit |
|
| (2,931,139 | ) |
|
| (2,751,779 | ) |
Accumulated other comprehensive income |
|
| 66 |
|
|
| 132 |
|
Total stockholders’ equity |
|
| 343,502 |
|
|
| 273,964 |
|
Total liabilities and stockholders’ equity |
| $ | 747,023 |
|
| $ | 803,179 |
|
Condensed Consolidated Statements of Cash Flows | ||||||||
(In thousands) | ||||||||
|
| Nine Months Ended | ||||||
|
| 2026 |
| 2025 | ||||
Cash flows from operating activities: |
|
|
|
| ||||
Net loss |
| $ | (179,360 | ) |
| $ | (216,184 | ) |
Stock-based compensation |
|
| 17,092 |
|
|
| 14,320 |
|
Depreciation and amortization |
|
| 11,988 |
|
|
| 12,511 |
|
Gain on extinguishment of debt |
|
| (8,639 | ) |
|
| — |
|
Amortization of debt issuance costs |
|
| 1,187 |
|
|
| 1,721 |
|
Accretion of marketable securities purchased at a discount |
|
| (1,149 | ) |
|
| (5,380 | ) |
Other non-cash items |
|
| (11 | ) |
|
| (18 | ) |
Change in operating assets and liabilities: |
|
|
|
| ||||
Other current and non-current assets |
|
| 6,914 |
|
|
| (4,393 | ) |
Accounts payable |
|
| 977 |
|
|
| 5,014 |
|
Customer deposits |
|
| 1,925 |
|
|
| (4,295 | ) |
Other current and non-current liabilities |
|
| (12,643 | ) |
|
| 9,037 |
|
Net cash used in operating activities |
|
| (161,719 | ) |
|
| (187,667 | ) |
Cash flows from investing activities: |
|
|
|
| ||||
Capital expenditures |
|
| (121,468 | ) |
|
| (155,892 | ) |
Purchases of marketable securities |
|
| (72,081 | ) |
|
| (306,754 | ) |
Proceeds from maturities and calls of marketable securities |
|
| 226,499 |
|
|
| 492,505 |
|
Other investing activities |
|
| 10 |
|
|
| 8 |
|
Net cash provided by investing activities |
|
| 32,960 |
|
|
| 29,867 |
|
Cash flows from financing activities: |
|
|
|
| ||||
Payments of long-term debt |
|
| (11,170 | ) |
|
| — |
|
Payments of finance lease obligations |
|
| (179 | ) |
|
| (154 | ) |
Proceeds from issuance of common stock pursuant to at-the-market offering |
|
| 145,020 |
|
|
| 109,160 |
|
Transaction costs related to issuance of common stock pursuant to at-the-market offering |
|
| (3,748 | ) |
|
| (3,179 | ) |
Other debt and equity transaction costs |
|
| (247 | ) |
|
| — |
|
Proceeds from issuance of common stock pursuant to employee stock purchase plan |
|
| 476 |
|
|
| — |
|
Withholding taxes paid on behalf of employees on net settled stock-based awards |
|
| (1,808 | ) |
|
| (118 | ) |
Net cash provided by financing activities |
|
| 128,344 |
|
|
| 105,709 |
|
Net decrease in cash, cash equivalents and restricted cash |
|
| (415 | ) |
|
| (52,091 | ) |
Cash, cash equivalents and restricted cash at beginning of period |
|
| 175,715 |
|
|
| 210,885 |
|
Cash, cash equivalents and restricted cash at end of period |
| $ | 175,300 |
|
| $ | 158,794 |
|
|
|
|
|
| ||||
Cash and cash equivalents |
| $ | 144,007 |
|
| $ | 128,789 |
|
Restricted cash |
|
| 31,293 |
|
|
| 30,005 |
|
Cash, cash equivalents and restricted cash |
| $ | 175,300 |
|
| $ | 158,794 |
|
Use of Non-GAAP Financial Measures
This press release references certain financial measures that are not prepared in accordance with GAAP, including non-GAAP total operating expenses, Adjusted EBITDA and free cash flow. The Company defines non-GAAP total operating expenses as total operating expenses other than stock-based compensation, depreciation and amortization, and legal settlement expense. The Company defines Adjusted EBITDA as earnings before interest expense, income taxes, depreciation and amortization, stock-based compensation, legal settlement expense, and gain on extinguishment of debt. The Company defines free cash flow as net cash provided by operating activities less capital expenditures. None of these non-GAAP financial measures is a substitute for or superior to measures prepared in accordance with GAAP and should not be considered as an alternative to any other measures derived in accordance with GAAP.
The Company believes that presenting these non-GAAP financial measures provides useful supplemental information to investors about the Company in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects, and allowing for greater transparency with respect to key financial metrics used by its management in financial and operational-decision making. However, there are a number of limitations related to the use of non-GAAP measures and their nearest GAAP equivalents. For example, other companies may calculate non-GAAP measures differently or may use other measures to calculate their financial performance, and therefore any non-GAAP measures the Company uses may not be directly comparable to similarly titled measures of other companies.
A reconciliation of total operating expenses to non-GAAP total operating expenses for the three and nine months ended
|
| Three Months Ended |
| Nine Months Ended | |||||||||
|
| 2026 |
| 2025 |
| 2026 |
| 2025 | |||||
Total operating expenses |
| $ | 59,421 |
| $ | 66,531 |
|
| $ | 190,300 |
| $ | 225,788 |
Stock-based compensation |
|
| 6,148 |
|
| 4,719 |
|
|
| 17,092 |
|
| 14,320 |
Depreciation and amortization |
|
| 4,089 |
|
| 4,117 |
|
|
| 11,988 |
|
| 12,511 |
Legal settlement expense |
|
| — |
|
| (500 | ) |
|
| — |
|
| 2,375 |
Non-GAAP total operating expenses |
| $ | 49,184 |
| $ | 58,195 |
|
| $ | 161,220 |
| $ | 196,582 |
A reconciliation of net loss to Adjusted EBITDA for the three and nine months ended
|
| Three Months Ended |
| Nine Months Ended | ||||||||||||
|
| 2026 |
| 2025 |
| 2026 |
| 2025 | ||||||||
Net loss |
| $ | (58,756 | ) |
| $ | (64,417 | ) |
| $ | (179,360 | ) |
| $ | (216,184 | ) |
Interest expense |
|
| 1,732 |
|
|
| 3,250 |
|
|
| 5,554 |
|
|
| 9,737 |
|
Income tax expense |
|
| 30 |
|
|
| — |
|
|
| 90 |
|
|
| 11 |
|
Depreciation and amortization |
|
| 4,089 |
|
|
| 4,117 |
|
|
| 11,988 |
|
|
| 12,511 |
|
Stock-based compensation |
|
| 6,148 |
|
|
| 4,719 |
|
|
| 17,092 |
|
|
| 14,320 |
|
Legal settlement expense |
|
| — |
|
|
| (500 | ) |
|
| — |
|
|
| 2,375 |
|
Gain on extinguishment of debt |
|
| — |
|
|
| — |
|
|
| (8,639 | ) |
|
| — |
|
Adjusted EBITDA |
| $ | (46,757 | ) |
| $ | (52,831 | ) |
| $ | (153,275 | ) |
| $ | (177,230 | ) |
The following table reconciles net cash used in operating activities to free cash flow for the three and nine months ended
|
| Three Months Ended |
| Nine Months Ended | ||||||||||||
|
| 2026 |
| 2025 |
| 2026 |
| 2025 | ||||||||
Net cash used in operating activities |
| $ | (58,046 | ) |
| $ | (56,303 | ) |
| $ | (161,719 | ) |
| $ | (187,667 | ) |
Capital expenditures |
|
| (41,095 | ) |
|
| (51,484 | ) |
|
| (121,468 | ) |
|
| (155,892 | ) |
Free cash flow |
| $ | (99,141 | ) |
| $ | (107,787 | ) |
| $ | (283,187 | ) |
| $ | (343,559 | ) |
The Company has not provided a reconciliation of forward-looking free cash flow to the most directly comparable GAAP financial measures because such a reconciliation is not available without unreasonable efforts, due to the variability of these items and/or the fact that there is substantial uncertainty associated with predicting any future adjustments that the Company may make to its GAAP financial measures in calculating such non-GAAP financial measures.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261112164644/en/
For media inquiries:
Aleanna Crane – Vice President, Communications
news@virgingalactic.com
575.800.4422
For investor inquiries:
vg-ir@virgingalactic.com
949.774.7640
Source: